# EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA

> **NCT02975752** · — · COMPLETED · sponsor: **University Hospital, Essen** · enrollment: 48 (actual)

## Conditions studied

- Lung Adenocarcinoma Metastatic

## Interventions

- **GENETIC:** LC-RT-PCR and NGS

## Key facts

- **NCT ID:** NCT02975752
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02975752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02975752, "EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02975752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*